Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
7.85
+0.03 (0.38%)
At close: Apr 28, 2026, 4:00 PM EDT
7.85
0.00 (0.00%)
After-hours: Apr 28, 2026, 6:30 PM EDT
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $456.93 million as of April 28, 2026. Its market cap has increased by 15.13% in one year.
Market Cap
456.93M
Enterprise Value
474.19M
1-Year Change
15.13%
Ranking
Category
Stock Price
$7.85
Market Cap Chart
Since April 19, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.18B to $456.93M, a decrease of -79.06%. That is a compound annual growth rate of -26.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 455.18M | -3.63% |
| Dec 31, 2025 | 472.31M | -9.39% |
| Dec 31, 2024 | 521.27M | -84.36% |
| Dec 29, 2023 | 3.33B | 16.75% |
| Dec 30, 2022 | 2.86B | -76.89% |
| Dec 31, 2021 | 12.35B | 466.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eikon Therapeutics | 473.17M |
| Entrada Therapeutics | 466.56M |
| Ovid Therapeutics | 465.47M |
| Larimar Therapeutics | 461.24M |
| Candel Therapeutics | 460.72M |
| Prelude Therapeutics | 454.50M |
| Climb Bio | 453.80M |
| Aura Biosciences | 446.83M |